CEBPA bZIP框内插入/缺失突变定义CEBPA突变急性髓系白血病预后良好亚组
本研究分析CEBPA突变位点与类型对急性髓系白血病预后的影响,聚焦CEBPA bZIP框内插入/缺失突变(CEBPA bZIP-InDel-inf)亚型的临床与遗传特征。加权多变量分析识别出影响总生存和无复发生存的独立预后因素,并据此建立风险评分。
要点
- CEBPA bZIP-InDel-inf是CEBPA突变AML的预后良好亚型
- 该亚型预后优于CEBPA非InDel突变及其他bZIP突变类型
- 高白细胞、高原始细胞计数和M4/M5表型独立预测较差总生存
核心结论
- CEBPA bZIP-InDel-inf是CEBPA突变急性髓系白血病的预后良好亚型。
- 仍需进一步研究阐明bZIP结构域突变蛋白的作用。
研究设计与样本
- 构建总生存和无复发生存的删失模型,采用逆概率删失加权调整信息性删失,并在加权Cox回归中使用稳定权重。
- 基于多变量分析结果开发总生存和无复发生存风险评分。
主要发现
- 与CEBPA bZIP-InDel-inf相比,CEBPA非InDel突变预后更差。
- 在bZIP区域内,bZIP-InDel-inf的结局优于其他突变类型,尤其在双突变病例中。
- 加权多变量分析中,较高白细胞计数、较高原始细胞计数和M4/M5表型独立预测较差总生存。
- 较高变异等位基因频率(VAF)、CSF3R突变和较低血红蛋白独立预测较差无复发生存。
- 上述变量可实现清晰的总生存和无复发生存风险分层。
临床怎么用
- 对CEBPA突变AML患者应识别bZIP-InDel-inf亚型以辅助预后分层。
- 可结合白细胞计数、原始细胞计数、M4/M5表型、VAF、CSF3R突变和血红蛋白进行总生存与无复发生存风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study investigated how cytosine-cytosine-adenine-adenine-thymine (CCAAT)/enhancer-binding protein alpha (CEBPA) mutation sites and types affect the prognosis of acute myeloid leukaemia (AML). It specifically analysed the clinical and genetic features of AML patients harbouring CEBPA basic leucine zipper in-frame insertion/deletion (CEBPA bZIP-InDel-inf) mutations and identified prognostic factors in this subtype. Prognostic factors in CEBPA bZIP-InDel-inf subgroup were examined in depth. Overall survival (OS) and relapse-free survival (RFS) censoring models were built, informative censoring was adjusted using inverse probability of censoring weighting, and stabilized weights were applied in weighted Cox regression analyses. Risk scores for OS and RFS were then developed from multivariable results. Ninety-three patients with CEBPA mutation, 56 had CEBPA bZIP-InDel-inf. Compared with CEBPA bZIP-InDel-inf, CEBPA non-InDel had a worse prognosis. Within the bZIP region, bZIP-InDel-inf also showed better outcomes than other mutation types, especially in double-mutated cases. In weighted multivariate analysis, higher white blood cell count, blast cell count and M4/M5 phenotype independently predicted worse OS, while higher variant allele frequency (VAF), colony stimulating factor 3 receptor (CSF3R) mutation and lower haemoglobin predicted worse RFS. These variables enabled clear OS and RFS risk stratification. CEBPA bZIP-InDel-inf is a favourable CEBPA-mutated AML subtype. Further research is needed to elucidate the role of bZIP-domain-mutated proteins.
引用
- Yang Y, Tang Y, Yang K, et al. CCAAT/enhancer-binding protein alpha basic leucine zipper in-frame insertion/deletion (CEBPA bZIP-InDel-inf) defines a favourable-prognosis subgroup in CEBPA-mutated acute myeloid leukaemia. Br J Haematol. 2026. PMID: 42490742. doi:10.1111/bjh.70705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。